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SObjective: Patients frequently have an ‘‘enlarged thymus’’ incidentally identified on imaging. We sought to
determine whether thymectomy is appropriate in patients with diffusely enlarged thymus glands.
Methods:A retrospective review was conducted of patients undergoing thymectomy without myasthenia gravis
at 1 institution over 15 years.
Results:Of 117 patients undergoing thymectomy, 109 patients had complete data. Thirty-six had a gland judged
by the surgeon to be diffusely enlarged, and 73 had a discrete mass. Of the 36 diffusely enlarged thymus glands,
18 (50%) occurred in patients with no symptoms referable to the thymus. No patient (0/18; 0%) with an asymp-
tomatic diffusely enlarged thymus gland had a pathologic diagnosis that would have required resection (8 nor-
mal; 10 ‘‘hyperplasia’’). Of the 18 symptomatic patients with diffusely enlarged glands, 4 (22.2%) harbored
lymphoma, but none harbored thymoma or other tumor (P<.05; symptomatic vs asymptomatic). Of the 73
patients with discrete masses, 45 (61.6%) were symptomatic, and both the symptomatic and asymptomatic
patients had a high rate of pathologic diagnoses that represented an indication for resection (53.3% and
42.8%, respectively, harbored thymoma or other tumor). Of the 25 (of 109) patients initially having a diagnosis
of thymic hyperplasia, only 3 (12%) had true follicular hyperplasia on re-review of the pathologic condition.
Interestingly, an autoimmune disorder developed in 2 (67%) of these 3 patients on long-term follow-up.
Conclusions: Asymptomatic patients with diffusely enlarged thymus glands can be followed up expectantly
because they have a negligible incidence of significant thymic disease; symptomatic patients with diffusely
enlarged thymus glands may have lymphoma, so biopsy is appropriate. Half of patients with a discrete mass
have tumors requiring resection; imaging advances would be useful to better differentiate among patients within
this group. (J Thorac Cardiovasc Surg 2010;140:977-83)Although in recent years the function of the thymus gland
has come to be better defined,1-3 the association of an
‘‘abnormal’’ thymus with several autoimmune diseases
continues to be incompletely understood.4 Among these
diseases, myasthenia gravis is the most common, and sub-
stantial (though inconclusive) data have accumulated sug-
gesting that thymectomy has a positive impact on this
illness.5-7
Perhaps because of our sizeable experience with the min-
imally invasive procedure transcervical thymectomy in pa-
tients with nonthymomatous myasthenia gravis,6 we are
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The Journal of Thoracic and Cathymic abnormalities. Among these are a substantial num-
ber of patients who do not have myasthenia gravis but are
believed to have ‘‘abnormally enlarged’’ thymus glands
without a discrete mass. These patients are often asymptom-
atic and the enlarged gland is often identified incidentally
on a scan carried out for another reason. The finding of
the suspected abnormality of diffuse thymic enlargement
creates significant anxiety for both the patient and the refer-
ring physician. Although different surgeons at our institu-
tions have taken different approaches to this problem, the
overall outcome has been that a substantial number of thy-
mus glands considered ‘‘enlarged,’’ but without a discrete
mass, have been removed.
Is this the appropriate way to manage these patients?
Should they undergo thymectomy, biopsy, or simply be ob-
served? Is there a way to decide which patients should be
treated operatively and which observed expectantly?
To help resolve this set of questions, we reviewed our ex-
perience to test the following hypothesis: that a substantial
portion of patients with diffusely enlarged thymus glands
will harbor a pathologic process that would be an appropri-
ate indication for surgical resection.METHODS
We conducted a retrospective review of all patients without myasthenia
gravis who underwent thymectomy at our institution between 1991 andrdiovascular Surgery c Volume 140, Number 5 977
Abbreviation and Acronym
CT ¼ computed tomography
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the study; patients provided informed consent for telephone interview.
One hundred seventeen patients qualified for the study; of these, 109
were found to have complete records and were thus included in the analy-
sis. Referral notes, preoperative surgeons’ notes, imaging reports, operative
reports, and pathologic reports were all reviewed with special attention to
demographics, signs and symptoms, and the surgeon’s determination of
whether the thymus represented a diffusely enlarged gland versus a gland
containing a discrete mass. In patients whowere determined on initial path-
ologic diagnosis to demonstrate thymic hyperplasia, all slides were re-
reviewed by our most expert thymic pathologist to confirm or refute the
presence of true follicular hyperplasia. Patients who had not been seen in
our offices within 6 months of final data collection were contacted by tele-
phone for up-to-date clinical follow-up.FIGURE 1. A, Normal thymus in a 26-year-old patient. B, Normal
thymus in a 50-year-old patient.RESULTS
Among the 109 patients, 36 (33%) had a gland judged by
the surgeon to be a diffusely enlarged thymus gland,
whereas 73 (67%) had a thymus containing a discrete
mass. The glands were differentiated into these respective
groups on the basis of computed tomographic (CT) find-
ings. The diffusely enlarged thymus glands had a homoge-
nous appearance, although often denser on CT scan than the
fatty density of the typical involuted thymus, with preserva-
tion of normal thymic shape and contour, though judged
large for age by both the radiologist and the surgeon
(Figures 1 and 2). Patients with discrete thymic masses
exhibited a well-defined soft tissue mass in a background
of thymic tissue of different density, often altering the nor-
mal concave aspect of the junction of the gland with the me-
diastinal pleura (Figure 3).
There were 51 (47%) male and 58 (53%) female pa-
tients with a median age of 50 years (range, 12–91 years).
Among the 36 patients with diffusely enlarged thymus
glands, 18 (50%) patients were asymptomatic at presenta-
tion and the other 18 patients had symptoms anatomically
referable to the thymus, ranging from chest discomfort and
pain to shortness of breath. Additionally, among patients
ultimately given a diagnosis of lymphoma, 2 patients re-
ported night sweats. In the group with discrete masses
(n ¼ 73), only 28 (38.4%) patients were asymptomatic;
the remaining 45 (61.6%) patients had a range of symp-
toms (Table 1). We subsequently analyzed the data in detail
from the point of view of symptomatic versus asymptom-
atic patients.
For all patients, chest discomfort (n¼ 19), pain (n¼ 14),
and shortness of breath (n ¼ 11) were the most common
symptoms identified. Although cough and a sensation of
chest fullness were found with a higher incidence, fatigue
and dysphagia were seen only in patients with discrete978 The Journal of Thoracic and Cardiovascular Surgmasses. Hoarseness was reported in only 1 patient with a dif-
fusely enlarged thymus gland (Table 2).
Nearly 60% of patients (n ¼ 65) were found to have ab-
normal histologic features on initial evaluation. Thirty pa-
tients had thymoma (diffuse enlargement ¼ 0, discrete
mass ¼ 30), 25 patients had an initial pathologic diagnosis
of hyperplasia with or without a cyst (diffuse enlarge-
ment ¼ 17, discrete mass ¼ 8), 5 patients had lymphoma
(diffuse enlargement ¼ 4, discrete mass ¼ 1), and another
5 had tumors other than thymoma (diffuse enlarge-
ment ¼ 0, discrete mass ¼ 5) (Table 3). Among the other
tumors, 3 were classified as germ cell tumor, metastatic
renal cell carcinoma, and invasive neuroendocrine tumor,
and 2 other tumors were not classified and lacked definite
diagnosis.
When patients were grouped into asymptomatic and
symptomatic groups, we found that none of the 18 patients
with an asymptomatic diffusely enlarged thymus gland hadery c November 2010
FIGURE 2. A, Diffusely enlarged thymus in a 37-year-old patient. B,
Diffusely enlarged thymus in a 50-year-old patient.
FIGURE 3. Discrete thymus mass in a 74-year-old patient.
TABLE 1. Distribution of patients based on presence or absence of
symptoms
Diffusely enlarged
thymus gland (n ¼ 36)
Discrete mass
(n ¼ 73)
Asymptomatic (n ¼ 46) 18 (50%) 28 (38%)
Symptomatic (n ¼ 63) 18 (50%) 45 (62%)
Singla et al General Thoracic Surgery
G
T
San ultimate pathologic diagnosis that would have repre-
sented an indication for resection (0/18; the maximum cal-
culated risk of pathologic diagnosis with 95% confidence is
not greater than 17%).8 Eight (44.4%) of these patients
were found to have a normal thymus with or without a small
benign cyst, and the remaining 10 (55.6%) patients were
initially classified as having ‘‘hyperplasia’’ with or without
a small cyst (although on re-review of the pathologic find-
ings, only 3 patients were confirmed to have hyperplasia).
Of the patients with symptomatic diffusely enlarged thymus
glands, 4 (22.2%) were found to harbor lymphoma in the
thymus, but none harbored a thymoma or other tumor re-
quiring resection (P<.05, incidence of significant diagno-
ses among symptomatic vs asymptomatic diffusely
enlarged thymus glands) (Table 4).
As expected, in the discrete mass group, both the asymp-
tomatic and symptomatic patients had a high rate of patho-The Journal of Thoracic and Calogic diagnoses that represented a clear indication for
resection. Twelve (42.8%) patients in the asymptomatic
group and 24 (53.3%) in the symptomatic group were found
to have thymoma or other solid tumor, respectively (Table 4).
Of the 25 of 109 patients initially given a pathologic diag-
nosis of thymic hyperplasia, on re-review of the pathologic
findings only 3 (12%) had true follicular hyperplasia. Inter-
estingly, on long-term follow-up, an autoimmune disorder
developed in 2 (67%) of these 3 patients. These included
1 case of lupus erythematosis and 1 case of ulcerative colitis.
None of the other 22 patients with lesser degrees of ‘‘hyper-
plasia’’ had subsequent autoimmune disease.DISCUSSION
Thymus glands that are, or that appear to be, abnormally
enlarged clearly represent a diagnostic and therapeutic chal-
lenge for surgeons. Prior studies suggest that although preop-
erative imaging is reasonably successful in diagnosing
discrete thymic masses, it consistently fails to differentiate
between normal gland, hyperplasia, and small thymic
masses.9-11 Although several studies describe the widely
known relationship between age and size of the thymus
gland,12-14 the algorithms that have been proposed to
determine when a gland is or is not ‘‘abnormally’’ enlarged
for a given age are sufficiently complex to be extremely
difficult to apply in daily practice.13 Furthermore, there is
substantial variability in the rate of thymic involutionrdiovascular Surgery c Volume 140, Number 5 979
TABLE 2. Distribution of predominant symptoms among symp-
tomatic patients
Total patients with symptoms (n ¼ 63)
Symptoms
Diffusely enlarged
thymus gland (n ¼ 18)
Discrete mass
(n ¼ 45)
Chest discomfort (n ¼ 19) 8 11
Pain (n ¼ 14) 4 11
Shortness of breath (n ¼ 11) 2 9
Cough (n ¼ 9) 2 7
Fullness (n ¼ 4) 1 3
Fatigue (n ¼ 3) 0 3
Dysphagia (n ¼ 1) 0 1
Hoarseness (n ¼ 1) 1 0
TABLE 4. Pathologic diagnoses according to symptom status and
indication for surgical resection
Diffusely enlarged
thymus gland (n ¼ 36)
Discrete mass
(n ¼ 73)
Asymptomatic
(n ¼ 46)
0/18* (no significant
pathology seen)
12/28 (thymoma/other
solid tumor)
Symptomatic
(n ¼ 63)
4/18* (all lymphomas) 24/45 (thymoma/other
solid tumor)
*Denotes P<.05 between asymptomatic and symptomatic diffusely enlarged thymus
glands.
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thymic tissue between individuals of the same age.12,14
Inasmuch as the size of the gland can also vary with
conditions like stress and inflammatory disorders,16 it re-
mains a significant challenge to try to predict pathologic di-
agnoses on the basis of radiographic findings alone.
The major finding of our study is to disprove our hypoth-
esis that a substantial portion of patients with diffusely
enlarged thymus glands will harbor a pathologic process
that would be an appropriate indication for surgical resec-
tion. Our finding, in fact, was nearly the opposite of this.
We found that not a single patient with a diffusely enlarged
thymus gland harbored a thymic tumor that required resec-
tion. The only pathologic process identified within these
thymuses was lymphoma in 4 cases, which perhaps would
have been more appropriately managed by biopsy than re-
section (though little or no harm is/was done with the resec-
tion being able to be performed by the minimally invasive
procedure, transcervical thymectomy).
Additionally, all patients with diffusely enlarged thymus
glands who had a diagnosis of lymphoma had symptoms re-
ferable to the thymus. Every patient who was asymptomatic
and had a diffusely enlarged gland was found to have a nor-
mal gland. We believe that our findings establish, then, that
the presence or absence of symptoms in patients with dif-
fusely enlarged thymus glands is a valuable piece of infor-
mation that the surgeon can use to determine whether to
operate or take an expectant approach. Specifically, our
findings suggest that patients with symptomatic diffuselyTABLE 3. Distribution of patients based on initial histologic
characteristics
Histology
Diffusely enlarged
thymus gland (n ¼ 36)
Discrete mass
(n ¼ 73)
Normal  cyst (n ¼ 44) 15 29
Hyperplasia  cyst (n ¼ 25) 17 8
Thymoma (n ¼ 30) 0 30
Lymphoma (n ¼ 5) 4 1
Other tumors (n ¼ 5) 0 5
980 The Journal of Thoracic and Cardiovascular Surgenlarged thymus glands should undergo thymic biopsy,
whereas patients without symptoms should be followed up
with serial radiographic evaluation. If the thymus remains
unchanged over 5 years (a rather lengthy period chosen con-
servatively inasmuch as thymomas can be very slow-
growing), we believe that follow-up can be terminated.
The benign thymic cysts identified within the thymic tis-
sue in some of the patients in our study were small and sub-
tle on preoperative imaging. Nearly all were in fact
incidental findings on pathologic examination. Patients
with radiographically prominent thymic cysts present a dif-
ferent sort of clinical challenge that has not been carefully
studied. We believe that unilocular, noncalcified, thin-
walled, simple fluid-density thymic cysts that are asymp-
tomatic are highly likely to be benign and can be observed.
Symptomatic cysts or cysts lacking these benign radio-
graphic features should be resected, preferably by a trans-
cervical or other minimally invasive approach. If any cyst
grows, we believe it should be resected, and certainly any
patient who chooses to have even a benign-appearing cyst
observed must be counseled that there is some chance that
a cystic thymoma (malignant cyst) is present.
Another interesting finding of our study is the fact that,
although on re-review of pathologic characteristics true thy-
mic follicular hyperplasia were found to be rare (only 3
cases), its presence seems in our limited sample to be highly
associated with the ultimate development of some type of
autoimmune disease. Such a process ultimately developed
in 2 of the 3 patients with true follicular hyperplasia. This
suggests a pathophysiologic relationship between thymic
follicular hyperplasia and autoimmune disorders. This is
obviously consistent with the widely known association of
thymic abnormalities with myasthenia gravis, but also
with the less widely known association of thymic abnormal-
ities with other autoimmune disorders17-19 and with the
association of thymectomy with resolution in some of
these disorders.19,20 We believe that additional prospective
study of thymectomy as a therapy for the more common
of these autoimmune disorders would be reasonable.
In distinct contrast to patients with diffusely enlarged
thymus glands, nearly half of all patients with discrete
masses proved to have tumors that should be resected. An
alternative way of looking at this, however, is thatery c November 2010
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found to have normal thymic pathologic conditions and so
will have undergone what might be termed an unnecessary
procedure. The presence or absence of symptoms was not
found to be useful in selecting patients with discrete thymic
masses requiring an intervention as it appears to be in pa-
tients with diffusely enlarged thymus glands.
With regard to a role for functional imaging, the available
evidence suggests that positron emission tomographic scan-
ning has only marginal utility in differentiating benign from
malignant processes within the thymus.21,22 At our insti-
tutions, we do not employ positron emission tomographic
scans to aid in the differential diagnosis of enlarged
thymus glands unless there is a history of or clinical
suspicion of lymphoma, which is generally markedly
fluorodeoxyglucose-avid. Future refinements in nuclear tu-
mor imaging or other radiologic techniques that may help to
delineate processes that should/should not be resected
would represent major advances in this field.
Although this study is obviously limited by its retrospec-
tive nature and its modest sample size, we believe that the
perfect correlation that we have found between an asymp-
tomatic presentation and the discovery of benign pathologic
conditions in diffusely enlarged thymus glands is suffi-
ciently impressive to guide management decisions. We rec-
ommend that patients with diffusely enlarged thymus
glands and no symptoms referable to the thymus undergo
observation with serial CT scanning while those with symp-
toms undergo thymic biopsy.
We thank Makoto Katsumata, PhD, for his contribution to sta-
tistical analyses.References
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DrMichaelWeyant (Aurora, Colo). I thank the authors for pro-
viding me with the manuscript and slides well ahead of the dead-
line. I enjoyed the paper very much.
Dr Singla, you and your colleagues have been able to address
a clinical scenario that is frequently encountered by thoracic sur-
geons. Until now, we have had no concrete recommendations
about how to deal with the problem. I think your series represents
the largest published to date regarding this phenomenon. The most
interesting aspect of your presentation deals with the diffusely en-
larged thymus, and I have a few questions.
Your data state that 4 of the 36 patients who had resection of
a diffusely enlarged thymus had abnormal pathologic features,
and they were lymphomas in all 4 of the cases. Inasmuch as 4 of
the patients were symptomatic and in half the patients who had
no symptoms no abnormal pathologic condition was demon-
strated, you recommend that if a patient has no symptoms and a dif-
fusely enlarged thymus, he or she can be monitored without
resection. I would like to play the devil’s advocate: Most of us
find it very difficult to attribute the true symptoms of the patient
to the thymus; the symptoms are very nonspecific and unreliable.
Therefore, you could use that as one of the limitations of your
study in gauging whether the patient’s symptoms are truly attribut-
able to the thymus. In that setting, if you look at the other side of
the argument, you would say that in 4 of these 36 patients who
have a diffusely enlarged thymus, greater than 10% of the time
you find abnormal pathologic features. You actually may be able
to submit an opposite conclusion—maybe resection should berdiovascular Surgery c Volume 140, Number 5 981
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are so unreliable. May I have your comments on that?
Dr Singla. You are correct that 4 of the patients with diffusely
enlarged thymus glands and symptoms actually had lymphoma,
and our recommendation is that for patients with lymphoma bi-
opsy is probably preferable (since it is less morbid) to resection.
In most instances, a CT-guided core needle biopsy will be suffi-
cient, but if more tissue is needed a Chamberlain procedure can
be done. Having said this, for the rest of the patients—those who
clearly have no symptoms—our recommendation is to wait and
watch. One could wait for 3 to 6 months and then scan them again
with little risk of missing anything. It is unlikely that even thy-
moma will become metastatic in 3 to 6 months. If the first scan
is unchanged, one could then do a scan yearly after that for about
5 years. Our data support the theory that nearly all of those patients
will never need surgery.
I think that one should have a low threshold to biopsy if any
symptoms are present that can be related in any way to the thymus.
This would include any lymphoma-type symptoms (for example,
‘‘B’’ symptoms) or symptoms that can result from compression
of structures around the thymus (such as cough or chest pain).
Dr Weyant.My second comment relating to your biopsy point
is that it might be wiser to resect the thymus rather that doing a bi-
opsy in these patients because of the amount of tissue required and
the fact that it is quite difficult to get adequate biopsy tissue. All of
the abnormal pathologic features you have demonstrated were
lymphoma.
Dr Singla. I shall ask Dr Shrager, my senior surgeon, to respond
because he has more experience doing these operations. Let me
ask him for some comments.
Dr Shrager. If you can do a transcervical thymectomy—if you
know how to do that—then maybe it is not unreasonable to do
a thymectomy in the case of a symptomatic gland, because it prob-
ably is just as benign a procedure as doing a Chamberlain proce-
dure. If you have pathologists who are comfortable, with good
flow cytometry, in making a diagnosis of lymphoma on the basis
of a needle biopsy, then a core needle would probably be the
way to go in one of these symptomatic glands.
DrWeyant. In looking at the patients in whom you re-reviewed
the pathologic features for thymic hyperplasia, you found that in
all except 3 the diagnosis was refuted and changed after re-review.
What is the reasoning behind that? Why do you think after the re-
review the diagnosis was actually changed?
Dr Singla. That is a very good question. In discussing thymic
hyperplasia, a lot of pathologists who do not have in-depth expe-
rience with thymic diseases will call any gland with increase in
the weight or the size of the gland ‘‘hyperplastic.’’ On the first
time around in pathology, when a pathologist other than our key
thymic pathologist often reviewed the cases, the thymuses that
were enlarged but did not actually demonstrate histologic follicu-
lar hyperplasia were often classified as ‘‘thymic hyperplasia.’’
When we went back, we actually went more in depth into the his-
tologic characteristics and found that most of those patients did not
demonstrate true histologic thymic follicular hyperplasia. There is
a difference between follicular hyperplasia (which is a histologic
finding) and simple enlargement of the gland. It is actually the fol-
licular hyperplasia that has been closely associated with autoim-
mune diseases, and that was one of the reasons that we went982 The Journal of Thoracic and Cardiovascular Surgback to see whether these thymic hyperplasias were actual exam-
ples of follicular hyperplasia or not.
Dr Robert Cerfolio (Birmingham, Ala).Are you sure you stud-
ied the right patients, or should you have studied patients like the
45 or 50 I have in my practice that I have not operated on and fol-
low up every year with a CT scan?
Dr Singla. I think we did our best to study these patients in de-
tail. We did go into depth in reading all the notes and talking with
these patients.
Dr Cerfolio. Did you study any of the patients who did not get
operated on?
Dr Singla. No, sir. These patients were all patients who had
been operated on.
Dr Cerfolio. Are you sure you studied the right patients or
should you go back and look at patients with enlarged glands
who have been followed up and have never undergone surgical re-
section and see how they did?
Dr Singla. That is a very good suggestion.We can do that, but at
present in the current data I only have patients that were operated
on.
Dr Cerfolio. I do not think that any new technology that makes
an operation less minimally invasive or easier to do or to recover
from should change the indication for surgery. For example, I
am doing lots of robotic thymectomies now. They are fun and
the patients go home the next day. You had mentioned that the
fact that you can do these from the neck might influence your in-
dication. Do you think that is true or should it be the patient’s anx-
iety that influences your decision, or the anatomic features of the
gland itself, and not the surgical approach?
Dr Singla. Dr Cerfolio, I did not say that doing transcervical
thymectomy should influence our indications. I said that in the
past it may have influenced our decision before we knew that it
was safe to leave many of these untouched. With the results of
this study, I think we can now see that many of the patients in
whom we performed thymectomy, partly because of the availabil-
ity of this simple approach, could safely have been left without sur-
gical intervention.
However, patients do have anxiety, especially when they have
been referred and told that they have a mass. Anybody in this au-
diencewhowas told that he or she had a mass would want answers,
so a lot does have to do with patient anxiety. In the scenario that
you have stated, that you have more advanced technology, yes,
we can definitely go in and operate on these patients safely. At
the same time, if we do not need to operate on these patients,
then we should not.
DrCerfolio.You sound like a great politician, so let me try to pin
down your position. Does the fact that you can do an operation min-
imally invasively change your indication for surgery: yes or no?
Dr Singla. I would prefer to ask Dr Shrager to answer that ques-
tion, but I would say no.
Dr Frederic Grannis (Duarte, Calif). Thank you for doing this
study. It gives very good information on a common problem. We
know from the data from the leukocytapheresis (LCAP) study that
if you use a CT scan to screen people for lung cancer, you find at
least 3 thymic enlargements in 1000 patients, maybe more. Thus,
this is a common problem that we need to learn how to manage.
I want to ask you 2 specific questions. First, did you do positron
emission tomographic scans on any of these patients? Doesery c November 2010
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a nonthymoma?
Second, recently we avoided surgery in a patient with diffuse
mass in the thymus because of hyperthyroidism. After that
patient was treated for hyperthyroidism, the thymic hyperplasia
resolved.
Dr Singla. Thank you, sir. With regard to your first question,
there have been some small studies using positron emission
tomographic scans in trying to read thymomas and other thymic
disorders. Some of these studies have suggested that such scans
can be useful. After discussing this with my colleagues and senior
colleagues, we believe that the data are not robust enough to say
that the positron emission tomographic scan alone would be suffi-
cient to give us the correct indication or correct information.
I think it is a combination of what we are suggesting is a combina-The Journal of Thoracic and Cation; a combination of signs and symptoms along with the CT scan
would be more appropriate at this stage in helping make the deci-
sion on how to proceed. In the coming years, with more informa-
tion coming, I think the positron emission tomographic scan may
add a lot of information. A negative positron emission tomo-
graphic scan would certainly be reassuring in patients on whom
you decide to follow up rather than operate.
Second, as you mentioned with the thyroid disorders, there are
clearly several diseases that are widely known to cause thymic
enlargement, and being aware of these is an important way to avoid
unnecessary thymectomy. Besides Graves disease, another com-
mon one is postchemotherapy rebound enlargement of the thymus.
I am not sure whether these represent actual follicular hyperplasia
or just enlargement, but they generally resolve with time or with
resolution of the underlying problem (eg, hyperthyroidism).rdiovascular Surgery c Volume 140, Number 5 983
